|Bid||203.00 x 60500|
|Ask||205.00 x 66200|
|Day's Range||201.30 - 206.20|
|52 Week Range||141.54 - 206.20|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Lonza Group AG agreed to buy U.S. capsule maker Capsugel SA from KKR & Co. for $5.5 billion, as the Swiss biotech and specialty chemicals company seeks to focus more on health care.
Lonza Group AG agreed to buy InterHealth Nutraceuticals for as much as $300 million, a sign the Swiss chemical maker may be back on the hunt for major acquisitions after a break of almost five years.
Lonza Group AG raised its guidance for 2016 after demand for the Swiss company’s drug ingredient manufacturing services grew and savings bolstered margins in the first half.